Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Clinical trial NCT00295854 · COMPLETED

Trial details

NCT number: NCT00295854
Sponsor: MediciNova
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Interstitial Cystitis

Start date: 2005-05-01
Primary completion: 2006-10-01
Enrollment: 296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.